# Virtu Financial, Inc.: financial statements, quarterly

VIRT · NYSE · CIK 1592386 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/virt.md) · [Financials](/companies/virt/financials.md) · [Filings](/companies/virt/filings.md) · [Insiders](/companies/virt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/virt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [110](/filings/0001592386-24-000101.md) | [114 d](/filings/0001592386-26-000009.md) | [119](/filings/0001592386-25-000080.md) | [126](/filings/0001592386-25-000123.md) | [132](/filings/0001592386-25-000149.md) | [140 d](/filings/0001592386-26-000009.md) | [151](/filings/0001592386-26-000016.md) | [154](/filings/0001592386-26-000028.md) | [154](/filings/0001592386-25-000149.md) | [157 d](/filings/0001592386-26-000009.md) | [187](/filings/0001592386-26-000016.md) | [180](/filings/0001592386-26-000028.md) |
| Income tax | $m | [20.5](/filings/0001592386-24-000101.md) | [10.1 d](/filings/0001592386-26-000009.md) | [28.5](/filings/0001592386-25-000080.md) | [27.3](/filings/0001592386-25-000123.md) | [28.1](/filings/0001592386-25-000149.md) | [26.5 d](/filings/0001592386-26-000009.md) | [34.1](/filings/0001592386-26-000016.md) | [54.0](/filings/0001592386-26-000028.md) | [30.9](/filings/0001592386-25-000149.md) | [63.0 d](/filings/0001592386-26-000009.md) | [63.0](/filings/0001592386-26-000016.md) | [57.6](/filings/0001592386-26-000028.md) |
| Net income | $m | [61.9](/filings/0001592386-24-000101.md) | [5.5 d](/filings/0001592386-26-000009.md) | [55.8](/filings/0001592386-25-000080.md) | [66.6](/filings/0001592386-25-000123.md) | [60.0](/filings/0001592386-25-000149.md) | [94.1 d](/filings/0001592386-26-000009.md) | [99.7](/filings/0001592386-26-000016.md) | [151](/filings/0001592386-26-000028.md) | [77.6](/filings/0001592386-25-000149.md) | [140 d](/filings/0001592386-26-000009.md) | [182](/filings/0001592386-26-000016.md) | [151](/filings/0001592386-26-000028.md) |
| Diluted EPS | $ per share | [0.63](/filings/0001592386-24-000101.md) | not reported | [0.59](/filings/0001592386-25-000080.md) | [0.71](/filings/0001592386-25-000123.md) | [0.64](/filings/0001592386-25-000149.md) | not reported | [1.08](/filings/0001592386-26-000016.md) | [1.65](/filings/0001592386-26-000028.md) | [0.86](/filings/0001592386-25-000149.md) | not reported | [1.99](/filings/0001592386-26-000016.md) | [1.63](/filings/0001592386-26-000028.md) |
| Basic EPS | $ per share | [0.63](/filings/0001592386-24-000101.md) | not reported | [0.59](/filings/0001592386-25-000080.md) | [0.71](/filings/0001592386-25-000123.md) | [0.65](/filings/0001592386-25-000149.md) | not reported | [1.09](/filings/0001592386-26-000016.md) | [1.65](/filings/0001592386-26-000028.md) | [0.86](/filings/0001592386-25-000149.md) | not reported | [1.99](/filings/0001592386-26-000016.md) | [1.63](/filings/0001592386-26-000028.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.7](/filings/0001592386-23-000075.md) | [0.8](/filings/0001592386-25-000055.md) | [0.4](/filings/0001592386-24-000049.md) | [0.7](/filings/0001592386-24-000076.md) | [0.7](/filings/0001592386-24-000101.md) | [0.9](/filings/0001592386-26-000009.md) | [0.7](/filings/0001592386-25-000080.md) | [0.8](/filings/0001592386-25-000123.md) | [0.7](/filings/0001592386-25-000149.md) | [1.1](/filings/0001592386-26-000028.md) | [1.0](/filings/0001592386-26-000016.md) | [1.1](/filings/0001592386-26-000028.md) |
| Total assets | $bn | [17.6](/filings/0001592386-23-000075.md) | [14.5](/filings/0001592386-25-000055.md) | [12.8](/filings/0001592386-24-000049.md) | [13.9](/filings/0001592386-24-000076.md) | [14.4](/filings/0001592386-24-000101.md) | [15.4](/filings/0001592386-26-000009.md) | [17.5](/filings/0001592386-25-000080.md) | [19.3](/filings/0001592386-25-000123.md) | [21.3](/filings/0001592386-25-000149.md) | [20.2](/filings/0001592386-26-000028.md) | [25.1](/filings/0001592386-26-000016.md) | [27.5](/filings/0001592386-26-000028.md) |
| Total liabilities | $bn | [16.1](/filings/0001592386-23-000075.md) | [13.1](/filings/0001592386-25-000055.md) | [11.4](/filings/0001592386-24-000049.md) | [12.5](/filings/0001592386-24-000076.md) | [13.0](/filings/0001592386-24-000101.md) | [13.9](/filings/0001592386-26-000009.md) | [16.0](/filings/0001592386-25-000080.md) | [17.7](/filings/0001592386-25-000123.md) | [19.6](/filings/0001592386-25-000149.md) | [18.2](/filings/0001592386-26-000028.md) | [22.9](/filings/0001592386-26-000016.md) | [25.2](/filings/0001592386-26-000028.md) |
| Long-term debt | $bn | [1.8](/filings/0001592386-23-000075.md) | [1.7](/filings/0001592386-25-000055.md) | [1.7](/filings/0001592386-24-000049.md) | [1.7](/filings/0001592386-24-000076.md) | [1.7](/filings/0001592386-24-000101.md) | [1.7](/filings/0001592386-26-000009.md) | [1.7](/filings/0001592386-25-000080.md) | [1.7](/filings/0001592386-25-000123.md) | [2.0](/filings/0001592386-25-000149.md) | [2.0](/filings/0001592386-26-000028.md) | [2.0](/filings/0001592386-26-000016.md) | [2.0](/filings/0001592386-26-000028.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [1.3](/filings/0001592386-23-000075.md) | [1.2](/filings/0001592386-25-000055.md) | [1.2](/filings/0001592386-24-000049.md) | [1.2](/filings/0001592386-24-000076.md) | [1.2](/filings/0001592386-24-000101.md) | [1.3](/filings/0001592386-26-000009.md) | [1.3](/filings/0001592386-25-000080.md) | [1.4](/filings/0001592386-25-000123.md) | [1.5](/filings/0001592386-25-000149.md) | [1.6](/filings/0001592386-26-000028.md) | [1.7](/filings/0001592386-26-000016.md) | [1.9](/filings/0001592386-26-000028.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [170 d](/filings/0001592386-24-000101.md) | [348 d](/filings/0001592386-26-000009.md) | [(395)](/filings/0001592386-25-000080.md) | [491 d](/filings/0001592386-25-000123.md) | [112 d](/filings/0001592386-25-000149.md) | [391 d](/filings/0001592386-26-000009.md) | [15.0](/filings/0001592386-26-000016.md) | [62.8 d](/filings/0001592386-26-000028.md) | [(68.7) d](/filings/0001592386-25-000149.md) | [509 d](/filings/0001592386-26-000009.md) | [(0.1)](/filings/0001592386-26-000016.md) | [117 d](/filings/0001592386-26-000028.md) |
| Capital expenditure | $m | [2.4 d](/filings/0001592386-24-000101.md) | [13.5 d](/filings/0001592386-26-000009.md) | [2.8](/filings/0001592386-25-000080.md) | [3.9 d](/filings/0001592386-25-000123.md) | [5.9 d](/filings/0001592386-25-000149.md) | [(0.2) d](/filings/0001592386-26-000009.md) | [5.7](/filings/0001592386-26-000016.md) | [5.2 d](/filings/0001592386-26-000028.md) | [8.0 d](/filings/0001592386-25-000149.md) | [3.9 d](/filings/0001592386-26-000009.md) | [5.6](/filings/0001592386-26-000016.md) | [19.0 d](/filings/0001592386-26-000028.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [(0.4) d](/filings/0001592386-23-000075.md) | [1.6 d](/filings/0001592386-26-000009.md) | [0.0](/filings/0001592386-25-000080.md) | [0.0 d](/filings/0001592386-25-000123.md) | [0.0 d](/filings/0001592386-25-000149.md) | [0.0 d](/filings/0001592386-26-000009.md) | [1.6](/filings/0001592386-26-000016.md) | [0.0 d](/filings/0001592386-26-000028.md) | [0.0 d](/filings/0001592386-25-000149.md) | [0.0 d](/filings/0001592386-26-000009.md) | [0.0](/filings/0001592386-26-000016.md) | [0.0 d](/filings/0001592386-26-000028.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [103](/filings/0001592386-23-000075.md) | [97.8](/filings/0001592386-24-000049.md) | [95.0](/filings/0001592386-24-000076.md) | [93.4](/filings/0001592386-24-000101.md) | [89.0](/filings/0001592386-25-000080.md) | [88.4](/filings/0001592386-25-000123.md) | [87.5](/filings/0001592386-25-000149.md) | [86.0](/filings/0001592386-26-000016.md) | [85.5](/filings/0001592386-26-000028.md) | [84.8](/filings/0001592386-25-000149.md) | [86.1](/filings/0001592386-26-000016.md) | [87.6](/filings/0001592386-26-000028.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.